← Open Payments lookup

MARCUS FINCH: Open Payments

NPI 1114969656 · PETAL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$571 in 32 payments from 13 companies in 2025. Trend: 2023 $819 · 2024 $365 · 2025 $571

Food & beverage: $571
CompanyPaymentsAmount
ABBVIE INC.6$115
Abbott Laboratories3$73
Novo Nordisk Inc4$68
Lilly USA, LLC4$64
Amgen Inc.3$45
PFIZER INC.2$42
GlaxoSmithKline, LLC.2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31
Boehringer Ingelheim Pharmaceuticals, Inc.2$30
Exact Sciences Corporation1$21

Products named: QULIPTA, FREESTYLE LIBRE 3, MOUNJARO, REPATHA, CAPLYTA, JARDIANCE, PREVNAR 20, The Cologuard Plus Collection Kit.

Industry payments across MS — which companies pay providers there.